OncoSec to Present at the Ladenburg Thalmann 2019 Healthcare Conference

SAN DIEGO and PENNINGTON, N.J., Sept. 20, 2019 /PRNewswire/ — OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O’Connor, President and Chief Executive Officer of OncoSec, will present a company overview at the Ladenburg Thalmann 2019 Healthcare Conference on Tuesday, September 24, 2019, at 3:30 p.m. Eastern Time in New York, NY.

A live audio webcast of the presentation will be available on the Investors section of OncoSec’s website at https://ir.oncosec.com/, where it will be archived for approximately 30 days.

Download Best WordPress Themes Free Download
Download WordPress Themes Free
Download Premium WordPress Themes Free
Download Premium WordPress Themes Free
online free course
download intex firmware
Download Best WordPress Themes Free Download
ZG93bmxvYWQgbHluZGEgY291cnNlIGZyZWU=